Pediatrix Medical集团盘前股价大涨8.43%,引发市场广泛关注。
公司发布的2024年第四季度业绩报告显示,营收和盈利均超出市场预期,成为推升股价上涨的主要利好因素。
具体来看,公司当季每股收益0.51美元,高于分析师预期的0.37美元,同比增长59.38%;营收5.02亿美元,也超过预期的4.86亿美元,同比增长1.19%。出色的业绩表现反映了公司经营状况良好,增添了投资者的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.